Skip to main content
Log in

The Current Status of Peritoneal Surface Oncology in Saudi Arabia

  • Original Article
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

Abstract

Peritoneal carcinomatosis (PC) is a common evolution of abdominal cancers. It may arise from the peritoneum itself (primary) or originate from another type of cancer especially those of gastrointestinal or gynecological origin (secondary). Without aggressive multimodal therapeutic approaches, PC is associated with a poor prognosis. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have been used to treat PC since 1990. In Saudi Arabia, the first CRS and HIPEC were done in 2008. In 2018, Saudi Arabia population is 32 millions of people and the demand for such procedures has grown up. This article gives outlines of the current status of peritoneal surface oncology in Saudi Arabia and the future perspective.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M, Baulieux J, Fontaumard E, Brachet A, Caillot JL, Faure JL, Porcheron J, Peix JL, François Y, Vignal J, Gilly FN (2000) Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 88(2):358–363

    Article  CAS  PubMed  Google Scholar 

  2. Sugarbaker PH, Cunliffe WJ, Belliveau J, de Bruijn EA, Graves T, Mullins RE, Schlag P (1989) Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Semin Oncol 16(4 Suppl 6):83–97

    CAS  PubMed  Google Scholar 

  3. Gilly FN, Sayag AC, Carry PY, Braillon GG, James IM, Volloch AA, Panteix GG (1991) Intra-peritoneal chemo-hyperthermia (CHIP): a new therapy in the treatment of the peritoneal seedings. Preliminary report. Int Surg 76(3):164–167

    CAS  PubMed  Google Scholar 

  4. Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, Baratti D, Deraco M, Elias D, Sardi A, Liauw W, Yan TD, Barrios P, Gómez Portilla A, de Hingh IHJT, Ceelen WP, Pelz JO, Piso P, González-Moreno S, van der Speeten K, Morris DL (2012) Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 30(20):2449–2456

    Article  PubMed  Google Scholar 

  5. Yan TD, Deraco M, Baratti D, Kusamura S, Elias D, Glehen O, Gilly FN, Levine EA, Shen P, Mohamed F, Moran BJ, Morris DL, Chua TC, Piso P, Sugarbaker PH (2009) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol 27(36):6237–6242

    Article  PubMed  Google Scholar 

  6. Goere D, Malka D, Tzanis D, Gava V, Boige V, Eveno C et al (2013) Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy? Ann Surg 257(6):1065–1071

    Article  PubMed  Google Scholar 

  7. Chia CS, You B, Decullier E, Vaudoyer D, Lorimier G, Abboud K et al (2016) Patients with peritoneal carcinomatosis from gastric cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is cure a possibility? Ann Surg Oncol 23(6):1971–1979

    Article  CAS  PubMed  Google Scholar 

  8. Saudi Cancer Registry (2015) Saudi Arabia cancer incidence report 2012. Saudi Cancer Registry, Riyadh

    Google Scholar 

  9. Al-Hanawi MK (2017) The healthcare system in Saudi Arabia: how can we best move forward with funding to protect equitable and accessible care for all? Int J Healthc 3(2):78

    Article  Google Scholar 

  10. Sebai ZAMW, Al-Zulaibani AA (2001) Health care services in Saudi Arabia: past, present and future. J Family Community Med 8(3):19–23

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Summary

The Saudi Arabia Peritoneal Surface Oncology Group needs more centers and more trained surgeons to cover for the rising demand. The next challenge will be to start the PC registry and start collaborative project between centers.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mohammad Alyami.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alyami, M., Mercier, F., Traiki, T.B. et al. The Current Status of Peritoneal Surface Oncology in Saudi Arabia. Indian J Surg Oncol 10 (Suppl 1), 33–36 (2019). https://doi.org/10.1007/s13193-019-00876-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13193-019-00876-y

Keywords

Navigation